Lucentis 10 mg/ml solution for injection

${arrow_up}$ Back to top

Active Ingredient:

ranibizumab

Company:

Novartis Pharmaceuticals UK Ltd See contact details

ATC code:

S01LA04

About Medicine

${medical_services}$

Prescription only medicine

My Account Area

${arrow_down}$

Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Audio/Video Live Chat HCP Med Info

${arrow_left}$

${arrow_right}$

Audio Guides to Lucentis - Click on the PLAY button to listen, or right click to save the audio file. To view or download a text version see the 'Risk Materials' tab.

Lucentis ( ranibizumab) - Patient Booklet (AMD) - Audio Version
This guide was created to help you better understand LUCENTIS® when used for the treatment of neovascular (wet) age-related macular degeneration (AMD)

Lucentis (ranibizumab) - Patient booklet (RVO) - Audio Version
This guide was created to help you better understand LUCENTIS® when used for the treatment of visual impairment due to retinal vein occlusion (RVO)

Lucentis (ranibizumab) - Patient booklet (CNV) - Audio Version
This guide was created to help you better understand LUCENTIS® when used for the treatment of visual impairment due to choroidal neovascularization (CNV).

Lucentis (ranibizumab) - Patient booklet (PDR/DMO)- Audio Version
This guide was created to help you better understand LUCENTIS® when used for the treatment of Diabetic macular oedema (DMO) and/or Proliferative diabetic retinopathy.